From: Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study
Name of the strain | D253 | D281 |
---|---|---|
MIC (mg/L) | 0 | 0 |
   Gentamicin (G) | 128 | 64 |
   Tobramycin (Tb) | 64 | 32 |
   Kanamycin (Ka) | 64 | 128 |
   Amikacin (Ak) | 32 | 32 |
   Streptomycin (St) | 64 | 64 |
   Cefazolin (Cz) | >256 | >256 |
   Ceftazidime (Ca) | 32 | 32 |
   Cefotaxime (Ce) | 256 | 64 |
   Ceftriaxone (Ci) | 256 | 512 |
   Cefepime (Cpm) | 64 | 64 |
   Ciprofloxacin (Cf) | 64 | 64 |
   Norfloxacin (Nx) | 64 | 32 |
   Piperacillin (Pc) | >256 | 512 |
   Amoxyclav (Ac) | 4 | 2 |
   Tetracycline (T) | 256 | 512 |
Resistance pattern type | 3 | 3 |
Resistance markers present in donor or test isolates | G, Tb, Ka, St, Ch, Cz, Cu, Ca, T, Ce, Ci, Cpm, Cf, Nx, Pc | G, Tb, Ka, St, Ch, Cz, Cu, Ca, T, Ce, Ci, Cpm, Cf, Nx, Pc |
Resistance markers transferred to the recipient ( E. coli J53) | Ca, Ce, Ci, T | Ca, Ce, Ci, Cf |
Total no. of transconjugants per plate | 1.7 × 102 | 2.1 × 102 |
Total no. of recepients ( E. coli J53) per plate | 107 | 107 |
Tansfer Frequency (Total No. of transconjugants per plate/Total no. of recepients per plate) | 1.7 × 10-5 | 2.1 × 10-5 |